Ovation Science Inc.
OVAT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 221.21% | 1,960.00% | -0.33% | -58.40% | -87.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 221.21% | 1,960.00% | -0.33% | -58.40% | -87.50% |
| Cost of Revenue | 100.00% | -27.27% | -- | -- | -28.57% |
| Gross Profit | 273.91% | 7,425.00% | -50.50% | -102.67% | -90.80% |
| SG&A Expenses | -21.79% | -27.46% | -16.92% | 19.13% | -26.86% |
| Depreciation & Amortization | -33.33% | 0.00% | 0.00% | 0.00% | -57.14% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.55% | -33.51% | -6.10% | -1.90% | -28.07% |
| Operating Income | 31.39% | 49.36% | 7.60% | -9.83% | 17.09% |
| Income Before Tax | 9.31% | 71.60% | -6.44% | -10.84% | 5.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.31% | 71.60% | -6.44% | -10.84% | 5.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.31% | 71.60% | -6.44% | -10.84% | 5.51% |
| EBIT | 31.39% | 49.36% | 7.60% | -9.83% | 17.09% |
| EBITDA | 31.38% | 49.52% | 7.64% | -9.87% | 16.70% |
| EPS Basic | 24.49% | 71.21% | 9.52% | 0.00% | 5.77% |
| Normalized Basic EPS | 25.81% | 71.43% | 7.69% | -7.41% | 3.13% |
| EPS Diluted | 24.49% | 71.21% | 9.52% | 0.00% | 5.77% |
| Normalized Diluted EPS | 25.81% | 71.43% | 7.69% | -7.41% | 3.13% |
| Average Basic Shares Outstanding | 19.98% | 0.00% | 16.40% | 12.89% | 0.00% |
| Average Diluted Shares Outstanding | 19.98% | 0.00% | 16.40% | 12.89% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |